Therefore, COX-2 downregulation via RNAi is one of the predominant mechanisms that inhibit the malignant biological behaviors of breast cancer by reducing the activity of VEGF-A and VEGF-C, which promote tumor angiogenesis and lymphangiogenesis. The gene discussed is VEGFC; the disease is neoplasm.